Low-Dose Warfarin Coupled With Lower Leg Compression Is Effective Prophylaxis Against Thromboembolic Disease After Hip Arthroplasty

Journal of Arthroplasty

Volumn 22, Issue 5, 2007, Pages 644-650

  Bern, Murray ^a,b   Deshmukh, Rahul V ^a   Nelson, Russell ^a   Bierbaum, Benjamin ^a,b   Sevier, Nancy ^a   Howie, Noreen ^a   Losina, Elena ^c,d   Katz, Jeffrey N ^b,d  

^a NEW ENGLAND BAPTIST HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

deep venous thrombosis; hip arthroplasty; hip replacement; pulmonary embolus; thromboembolic disease; warfarin

Indexed keywords

WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HOSPITAL DISCHARGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEG COMPRESSION; LOW DRUG DOSE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PROPHYLAXIS; PROTECTIVE CLOTHING; PROTHROMBIN TIME; TOTAL HIP PROSTHESIS; VENOUS THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; BANDAGES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEG; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PRESSURE; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; VENOUS THROMBOSIS; WARFARIN;

EID: 34547560384     PISSN: 08835403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arth.2006.07.001     Document Type: Article

References (28)

1. Katz J.N., Losina E., Barrett J., et al. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States Medicare population. J Bone Joint Surg Am 83A (2001) 1622
2. Phillips C.B., Barrett J.A., Losina E., et al. Incidence rates of dislocation, pulmonary embolism, and deep infection during the first six months after elective total hip replacement. J Bone Joint Surg Am 85A (2003) 20
3. Warwick D., Williams M.H., and Bannister G.C. Death and thromboembolic disease after total hip replacement. J Bone Joint Surg Br 77 (1995) 6
4. Dahl O.E., Gudmundsen T.E., Bjornara B.T., et al. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital: a 10-year prospective register of 3,954 patients. Acta Orthop Scand 74 (2003) 299
5. Harris W.H., McKusik K., Athanasoulis C.A., et al. Detection of pulmonary emboli after total hip replacement using serial C15O2 pulmonary scans. J Bone Joint Surg 66A (1984) 1388
6. Bern M.M., Lokich J.J., Wallock S.R., et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Int Med 112 (1990) 423
7. Bern M.M., Bothe Jr. A., Bistrian B., et al. Prophylaxis against central vein thrombosis with low-dose warfarin. Surgery 99 (1986) 216
8. Bern M.M., Bierbaum B., Wetzner S., et al. Very low-dose warfarin as prophylaxis against ultrasound detected deep vein thrombosis following primary hip replacement. Am J Hematol 71 (2002) 69
9. Francis C.W., Ricotta J.J., Evarts C.M., et al. Long-term clinical observations and venous functional abnormalities after asymptomatic venous thrombosis following total hip or knee arthroplasty. Clin Orthop Relat Res 232 (1988) 271
10. Kakkar V.V., Howe C.T., Flanc C., et al. Natural history of postoperative deep vein thrombosis. Lancet 2 (1969) 230
11. Philbrick J.T., and Becker D.M. Calf vein venous thrombosis. A wolf in sheep's clothing?. Arch Intern Med 148 (1988) 2131
12. Lotke P.A., Ecker M.L., Alavi A., et al. Indications for treatment of deep vein thrombosis following total knee replacement. J Bone Joint Surg Am 66 (1984) 202
13. Kearon C., Julian J.A., Math M., et al., for the McMaster Diagnostic Imaging Practice Guidelines Initiative. Noninvasive diagnosis of deep venous thrombosis. Ann Intern Med 128 (1998) 663
14. Francis C.W., Marder V.J., Evarts C.M., et al. Two-step warfarin therapy. Prevention of post-operative venous thrombosis without excessive bleeding. JAMA 249 (1983) 374
15. Vives M.J., Hozack W.J., Sharkey P.F., et al. Fixed minidose versus adjusted low-dose warfarin after total joint arthroplasty: a randomized prospective study. J Arthroplasty 16 (2001) 1030
16. Wilson M.G., Pei L.F., Malone K.M., et al. Fixed low-dose versus adjusted higher-dose warfarin following orthopedic surgery. A randomized prospective trial. J Arthroplasty 9 (1994) 127
17. Fordyce M.J., Baker A.S., and Staddon G.E. Efficacy of fixed minidose warfarin prophylaxis in total hip replacement. BMJ 303 (1991) 219
18. Dale C., Gallus A., Wycherley A., et al. Prevention of venous thrombosis with minidose warfarin after joint replacement. BMJ 303 (1991) 224
19. Sculco T.P., Colwell C.W., Pellegrini Jr. V.D., et al. Prophylaxis against venous thromboembolic disease in patients having total hip or knee arthroplasty. J Bone Joint Surg Am 84A (2002) 466
20. Westrich G.H., Farrell C., Bono J.V., et al. The incidence of venous thromboembolism after total hip arthroplasty: a specific hypotensive epidural anesthesia protocol. J Arthroplasty 14 (1999) 456
21. Warwick D., Harrison J., Glew D., et al. Comparison of the use of a foot pump with the use of low-molecular-weight heparin for the prevention of deep-vein thrombosis after total hip replacement. A prospective, randomized trail. J Bone Joint Surg Am 80 (1998) 1158
22. Dahl O.E., Gudmundsen T.E., Bjornara B.T., et al. Risk of clinical pulmonary embolism after joint surgery in patients receiving low-molecular-weight heparin prophylaxis in hospital. Acta Orthop Scand 74 (2003) 299
23. Hirsh J., Guyatt G., Albers G.W., et al. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: evidence-based guidelines. Chest 126 Suppl 3 (2004) S163
24. Hull R.D., Pineo G.F., Francis C., et al. Low-molecular-weight-heparin prophylaxis using dalteparin in close proximity to surgery vs. warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trail Investigators. Arch Intern Med 160 (2000) 2199
25. Planes A., Samama M.M., Lensing A.W., et al. Prevention of deep vein thrombosis after hip replacement-comparison between two low molecular weight heparins, tinzaparin and enoxaparin. Thromb Haemost 81 (1999) 22
26. Bern M.M. Observations on possible effects of daily vitamin K replacement, especially upon warfarin therapy. JPEN J Parenter Enteral Nutr (2004) 388
27. Dahl O.E., Andreassen G., Aspelin T., et al. Prolonged thromboprophylaxis following hip replacement surgery-results of a double-blind, prospective, randomized, placebo-controlled study with dalteparin. (Fragmin). Thromb Haemost 77 (1997) 26
28. Kearon C., Ginsberg J.S., Douketis J., et al. A randomized trail of diagnostic strategies after normal proximal vein ultrasonography for suspected deep venous thrombosis: d-dimer testing compared with repeated ultrasonography. Ann Intern Med 142 (2005) 490